Rabies Immune Globulin (Human) from Japan
Passive antibody preparation from human plasma of vaccinated donors, used post-exposure prophylaxis for rabies. HTS 3002.12.0090 covers this as other antisera/blood fractions for prophylactic therapeutic use. Biotech processes ensure high potency against rabies virus.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Rabies neutralizing antibody (RFFIT) test reports mandatory for import validation
• Prior FDA notification via Prior Notice system for biologics expedites entry